Beyond SBDD: geometric deep learning in polypharmacology and multi-target drug design
Read the original at arxiv.org→arXiv:2607.20550v1 Announce Type: new Abstract: The traditional "one drug, one target" paradigm of structure-based drug design (SBDD) frequently proves inadequate for treating multifactorial diseases such as cancer...
Original headline: "Beyond SBDD: Geometric Deep Learning in Polypharmacology and Multi-target Drug Design"
Coverage timeline
- Jul 24, 04:00 UTC arXiv cs.LG lead source Beyond SBDD: Geometric Deep Learning in Polypharmacology and Multi-target Drug Design